Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Status Completed

Clinical Trial Summary

Many types of cancer are primarily treated with surgery and patient survival is directly related to the extent to which the tumor is able to be removed. It is often difficult for surgeons to distinguish tumor tissue from normal tissue or to detect tumor cells that have spread from the original tumor site, resulting in incomplete removal of the tumor and reduced patient survival. In addition, in some sites, such as the brain, it is critical to avoid damage to normal tissue around the tumor to prevent adverse effects of surgery on function. We hypothesize that BLZ-100 will improve surgical outcomes by allowing surgeons to visualize the edges of the tumor and small groups of cancer cells that have spread to other sites in real-time, as they operate.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Skin Neoplasms

Clinical Trial Details

NCT number	NCT02097875
Study type	Interventional
Source	Blaze Bioscience Australia Pty Ltd
Contact
Status	Completed
Phase	Phase 1
Start date	December 2013
Completion date	March 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00027586` - Imatinib Mesylate in Treating Patients With Metastatic Melanoma	Phase 2
Not yet recruiting	`NCT02230462` - Patient Satisfaction After Facial Reconstruction	N/A
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Completed	`NCT00224744` - Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage	Phase 3
Completed	`NCT03132012` - Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection	N/A
Terminated	`NCT00865878` - ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients	Phase 2
Not yet recruiting	`NCT05359419` - Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities	Phase 4
Active, not recruiting	`NCT00001813` - Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Completed	`NCT02046811` - Reducing Skin Cancer Risk in Childhood Cancer Survivors	N/A
Completed	`NCT02147080` - A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults	N/A
Completed	`NCT00007631` - Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer	Phase 3
Completed	`NCT00847912` - CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial	Phase 4
Recruiting	`NCT02836548` - HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma	Phase 1/Phase 2
Completed	`NCT01482104` - New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)	N/A
Enrolling by invitation	`NCT04630886` - Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery	Early Phase 1
Completed	`NCT03012581` - Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types	Phase 2
Withdrawn	`NCT02813902` - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors	Phase 1
Not yet recruiting	`NCT02408835` - Negative Pressure Wound Therapy in Groin Dissection	N/A
Completed	`NCT00204789` - Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients	Phase 2
Completed	`NCT02310503` - Spanish Registry of Mohs Surgery